ABSTRACT Embryonic Stem Cells (ESCs) are derived from the inner cell mass of blastocysts. They have the unique potency to differentiate into diverse lineages. Hence, they are bestowed with the term pluripotency. Several mechanisms have been implicated in maintaining the pluripotency of ESCs. This review will focus on the role of signaling pathways in regulating ESC pluripotency among diverse mammalian species. A novel phylogenetic approach has been designed to understand the structural basis of divergence in the signaling pathways which modulate pluripotency among different species. Detailed insight into different signaling mechanisms indicates inhibition of Extracellular Related Kinase 1/2 (ERK 1/2) signaling as the key component regulating the pluripotency of ESCs. On the basis of recent advances made in this field, it can be hypothesized that expression of the transcription factor KLF4 and inhibition of ERK signaling may promote the establishment and maintenance of true ESCs from different mammalian species.
Introduction
The process of embryogenesis is initiated with the fertilization of a sperm with an ovum. The one-celled embryo divides to form the blastocyst (Fig. 1 ) comprising of inner cell mass (ICM) and trophectoderm. Within the ICM, an epiblast layer of cells form the inner core sandwiched between polar trophblast and hypoblast cells (Fig. 1 ). This region further develops in vitro into ESC. Back in 1981, Evans and Kaufman were the first to derive mouse ESCs (mESCs) from the mouse blastocyst (Evans & Kaufman, 1981) . It took more than a decade to establish the first pluripotent human ESCs (hESCs) (Thomson et al., 1998) and primate ESCs (Thomson et al., 1995) . ESCs have the inherent capacity to differentiate into any lineage and hence are termed as pluripotent. Also, they have the intrinsic potential to divide or self-renew indefinitely. These two characteristics formed the basis of exploiting ESCs for genetic manipulations (various genetic disorders) or in regenerative medicine and tissue replacement after injury or diseases. So, it is extremely significant to understand the mechanism responsible for the maintenance of pluripotency in ESCs.
Signaling molecules, transcription factors, cell cycle regulators and epigenetic modifications regulates intricate molecular mechanism of maintaining pluripotency of ESCs among wide range of mammalian species. Signaling mechanisms regulating the expression of pluripotency factors POU5F1, NANOG, SOX2
and KLF4 significantly differ in the context of species specification. Both extrinsic and intrinsic factors contribute towards the regulatory mechanisms involved in pluripotency. Extrinsic factors like Leukemia Inhibitory Factor (LIF), Bone morphogenic protein 4 (BMP4) or basic Fibroblast growth factor (bFGF) when supplemented to the ESC culture, induce signals that are transmitted through intracellular components and regulate the expression of pluripotency factors (Pera & Tam, 2010) . Intrinsic factors like ERK are present within the cell and in their active form generally induce the differentiation of mESCs. Hence, inhibition of these signaling pathways could maintain the pluripotency of mESCs.
ESCs have been isolated from mice to men. In spite of the importance of farm animals in agricultural and pharmaceutical application, the generation of true ESCs from these animals is still elusive. Animal models mimicking human anatomy are severely required to evaluate the safety and efficacy of cell therapies. But, due to technical problems in culturing and deriving ESCs from these animals and their inability to contribute to germ line, a detailed study on maintaining pluripotency of ESCs has been limited to fewer cases.
This review deals with signaling pathways implicated in maintain-ing pluripotency in ESCs isolated from different mammalian species. A novel phylogenetic approach has been included to provide a structural basis of the differential role of signaling pathways. The combinatorial role of a signaling pathway and transcription factor has been hypothesized to promote the maintenance and derivation of true ESCs from different mammalian species.
Intrinsic factors in regulation of pluripotency

ERK signaling
ESCs have an intrinsic property to differentiate spontaneously. So, inhibition of differentiation maintains the self-renewal character of mESCs. ERK1/2 signaling autoinductive stimulation by Fibroblast growth factor or FGF4 is implicated in inducing differentiation of mESCs. Suppression of FGF4/ERK signaling pathway promotes the self-renewal of mESCs . But, inhibition of FGF/ ERK signaling resulted in degeneration of mESC culture . So, to maintain metabolic activity, biosynthetic capacity and overall viability of mESCs, CHIR99021 (CH) is introduced in the culture condition to inhibit Glycogen synthase kinase 3 or GSK3 signaling. It could inhibit the differentiation towards neuronal lineage Bechard & Dalton, 2009 ) as well. Hence, dual inhibition of ERK and GSK3 signaling by PD0325901 (PD) and CH respectively restored the pluripotency in mouse as well as rat ESCs in a feeder free condition Bechard & Dalton, 2009; Buehr et al., 2008; Li et al., 2008) .
Pluripotency in ESCs is maintained by a set of transcription factors. They function through feedback regulatory circuit positively regulating their own genes. These factors activate genes encoding critical components of pluripotency while repress genes important for developmental processes. Maintenance of self-renewal and pluripotency of ES cells require a complex network of transcription factors namely Pou5f1, Sox2 and Nanog (Niwa et al., 2000; Masui et al., 2007; Chambers et al., 2007; He et al., 2009) . Another factor Klf4 was earlier found to be dispensable (Nakatake et al., 2006) . But, a triple RNAi approach of knocking down Klf2, Klf4 and Klf5, established the role of Klf circuitry in maintaining self-renewal state of mESCs (Jiang et al., 2008) . ERK1/2 binds at the C-terminal domain of KLF4 and phosphorylates it at Ser123 residue in mESCs (Kim et al., 2012) . This phosphorylation downregulate the transcriptional activity of Klf4 and induces differentiation of mESCs. Thus, inhibition of ERK signaling enhances Klf4 activity and in turn maintains the undifferentiated state of mESCs (Kim et al., 2012) .
On the contrary, downstream to FGF signaling, activation of ERKsignaling is associated with maintenance of pluripotency in hESCs.
PKC signaling
Inhibition of protein kinase C (PKC) isoforms maintain pluripotency in mESCs without the activation of STAT3 or inhibition of ERK/GSK3 signaling pathways (Dutta et al., 2011) . Atypical PKC isoform, PKCζ function is involved in the activation of Nfκb pathway during mESC differentiation. On inhibition of PKC signaling by the pharmacological drug, Gö6983, downregulation of Nfκb target genes were observed (Dutta et al., 2011) . Thus, an appropriate activity of PKC-signaling directly balances the self-renewal and differentiation status in mESCs and in rat ESCs as well (Rajendran et al., 2013) .
Aurora Kinase A/p53 signaling
Phosphoregulators play a key role in signal transduction. Screening of shRNAs for mESC-associated phosphoregulators revealed an essential role of Aurora kinase A or Aurka in maintaining the self-renewal state of mESCs . Loss of Aurka is coupled to stimulation in p53 activity and hence induces differentiation of ESCs towards ectoderm and mesoderm lineage . Thus, Aurka mediated p53 phosphorylation is essential for maintaining self-renewal and pluripotency in mESCs. But, only future studies will establish whether the function of Aurka is conserved among species or not.
Extrinsic factors in regulation of pluripotency
LIF and JAK/STAT3 signaling
Mouse ESCs can be cultured in vitro in an undifferentiated state in presence of LIF and serum (Smith et al., 1988) . LIF on binding to the receptor activates Janus kinase (JAK) and phosphorylates STAT3 at Tyr705 (Zhong et al., 1994; Niwa et al., 1998) . STAT3 essentially maintains the c-MYC level (Cartwright et al., 2005) and induces the KLF4 expression Additionally, Stat3 induced Pramel7 activity blocks the phosphorylation of ERK (Casanova et al., 2011) . Recently zeta-chain (TCR) associated protein kinase or Zap70, a Syk (spleen tyrosine kinase) family tyrosine kinase, has been found to negatively regulate the JAK/STAT3/c-MYC pathway and thus modulate the self-renewal capacity and differentiation ability of mESCs (Cha et al., 2010) . Zap70 interacts with SHP1 phosphatase and inhibits the phosphorylation of JAK, which in turn downregulate the STAT3 dependent c-MYC induction (Cha et al., 2010) .
Interestingly, LIF is unable to maintain the undifferentiated state of hESCs. Rather, in pluripotent hESCs, STAT3 do not localize within the nucleus and is incapable to activate its target genes (Dahéron et al., 2004) .
BMP4 signaling
In absence of serum, LIF alone could not maintain the undifferentiated nature of mESCs. But when mESCs are cultured in presence of BMP4 and LIF, they retain the undifferentiated status (Ying et al., 2003) . Dimeric BMP4 binds to type II receptor BMPR2 and facilitates the assembly of receptor heteromers (Yu et al., 2005) . The constitutively active kinase domains of type II receptors phosphorylate type I receptors, BMPR1 (BMPR1A, earlier known as ALK3 or BMPR1B, earlier known as ALK6) and the type I receptors in turn phosphorylate either of the receptor SMADs (SMAD1or SMAD5 or SMAD8) (Heldin et al., 1997; Kawabata et al., 1998; Derynck & Zhang, 2003) . SMAD4 joins as the co-activator to either of the R-SMADs to form the heteromeric complex (Derynck & Zhang, 2003) . Phosphorylated receptor-SMAD induces the expression of Id genes and represses genes implicated in neuroectoderm like Neurod, Ascl1 (Ying et al., 2003) . Downstream to SMAD2, BMP4 signaling modulates the H3K27 demethyase, Kdm6b and Dihydropyrimidinase-like 2 or Dpysl2 in maintaining pluripotency of mESCs (Fei et al., 2010a) .
Additionally, BMP4 can steadily attenuate the ERK activity by upregulating ERK-specific dual specificity phosphatase 9 (DUSP9) particularly in mESCs (Li et al., 2012; Qi et al., 2004) .
Interestingly, the definite role of BMP4 in regulating pluripotency of hESCs is still unresolved. Earlier, it was demonstrated that BMP4 induces differentiation of hESCs towards extra-embryonic lineages specifically trophblasts and inclusion of Noggin in culture condition prevents the differentiation of hESCs towards the extra-embryonic lineage (Xu et al., 2002) . But, in 2011, Bernardo et al., showed that BMP4 is responsible for the induction of differentiation towards mesoderm wherein the cells do express trophblast specific markers but to a lower extent (Bernardo et al., 2011) . However, recently, Amita et al., reported the generation of trophoblast specific cells from hESCs in presence of only BMP4 (Amita et al., 2013) . The differentiation was induced in a culture condition similar to the one used by Bernardo et al., (2011) although with a reduced level of expression of mesodermal markers. Hence, further validation is required to establish the role of BMP4 signaling in pluripotency of hESCs.
Wnt/b-catenin signaling
The canonical Wnt-pathway has been implicated in pluripotency of mESCs. According to the newly established model of Wnt signaling, Wnt induces the association of the destruction complex composed of DVL1, AXIN, APC, GSK3 and phosphorylated b-catenin with phosphorylated LRP (Clevers & Nusse, 2012) . This complex phosphorylates b-catenin but further blocks the ubiquitination by b-TrCP. As a result, newly synthesized b-catenin is accumulated in the cytosol and translocated into the nucleus (Clevers & Nusse, 2012) . The b-catenin/CBP complex binds to its target Tcf and Lef and induces the expression of Stat3 mRNA (Miyabayashi et al., 2007; Hao et al., 2006) . Independent of Tcf/Lef binding, stabilized b-catenin enhances Pou5f1 activity for the maintenance of pluripotency in mESCs (Kelly et al., 2011) .
In hESCs, it was reported that activating the Wnt/ b-catenin pathway with either WNT3A or a GSK3 inhibitor, BIO ((2'Z,3'E)-6-Bromoindirubin-3'-oxime), maintained the self-renewal of hESCs under feeder-free conditions (Sato et al., 2004) . Conversely, there have been reports where WNT3A or GSK3 inhibitors lead to differentiation of hESCs toward primitive streak and definitive endoderm lineages (Bone et al., 2011; Nakanishi et al., 2009) . So, the role of Wnt/b-catenin signaling in hESCs is controversial. Recently, Wnt/b-catenin signaling has been found to be inactive in the selfrenewal of hESCs (Davidson et al., 2012) . During self-renewal in hESCs, POU5F1 reportedly repress b-catenin signaling. So, targeted knockdown of POU5F1 activated b-catenin signaling in hESCs (Davidson et al., 2012) . A fluorescent reporter of b-catenin revealed that the enhanced expression of b-catenin is associated with induced differentiation in hESCs (Davidson et al., 2012) . Intriguingly, the fate of differentiation of hESCs corresponding to endogenous Wnt signaling is based on the heterogeneous culture of hESCs (Blauwkamp et al., 2012) . Human ESCs with a higher expression of Wnt predominantly differentiated towards endodermal and cardiac fates whereas hESCs expressing lower level of Wnt generated cells primarily from neuroectodermal lineage.
This phenomenon further incites a very significant characteristic of ESCs, that is, heterogeneity in culture condition. Basically, this inherent property of ESCs further regulates the response towards different signaling mechanisms and hence will be discussed in a later section.
FGF and Nodal/Activin signaling
FGF signaling is associated with induction of differentiation in mouse and rat ESCs Bechard & Dalton, 2009 ). Activin/Nodal signaling has been reported to promote mESC proliferation (Ogawa et al., 2007) and has been implicated especially in commitment towards mesendoderm (Fei et al., 2010b) .
But, FGF signaling could sustain the undifferentiated nature of hESCs. When cultured on feeder layers, hESCs maintain the undifferentiated state only in presence of bFGF (Thomson et al., 1998; Levenstein et al., 2006) . Exogenously added bFGF binds to the FGF receptors and activate ERK1/2 signaling responsible for maintaining pluripotency in hESCs (Kang et al., 2005) . FGF signaling also inhibits the spontaneous differentiation towards extra-embryonic lineage or neural-induction in hESCs (Greber et al., 2011) . Exogenous addition of bFGF induces the expression of insulin growth factor II (IGF-II) from autologously derived hESC fibroblast-like cells (hdFs) (Bendall et al., 2007) . The interaction between IGFR1/IGF-II contributes to the maintenance of stemness in hESCs (Bendall et al., 2007) .
When cultured on MEFs, addition of bFGF further activates the Nodal/Activin signaling by activating Activin A receptors (Greber et al., 2007) . Activin A receptors further phosphorylate SMAD2/3 and form a complex with co-activator SMAD4. The SMAD-complex induces the expression of NANOG in the nucleus and supports the maintenance of pluripotency of hESCs (Vallier et al., 2009a) .
PI3 kinase/AKT signaling
Phosphoinositide 3-kinase (PI3K) pathway is important for proliferation, survival, and maintenance of pluripotency in ESC. On activation of PI3K, secondary messengers are produced which transmit their effect through AKT, serine threonine kinase. AKT is implicated in different aspects of cellular metabolism and tumorigenesis. Earlier, a LIF-dependent activation of PI3K pathway was found to be responsible for regulating pluripotency in murine ESCs. On binding of LIF, gp130 is activated. The activated receptor then induces PI3K to phosphorylate PKB/AKT which in turn influences its downstream effectors to maintain the pluripotency in mESCs (Paling et al., 2004) . Later, in 2006, the active myristolated form of AKT was reported to maintain ESC self-renewal independent of LIF or BMP4 or Wnt/b-catenin signaling (Watanabe et al., 2006) . Activated PI3K/AKT might inhibit GSK3b signaling and hence could maintain the pluripotency in mouse as well as in primate (monkey) ESCs (Watanabe et al., 2006) .
Earlier reports suggested that inhibition of PI3K signaling promotes endodermal and mesodermal differentiation in hESCs (Mclean et al., 2007) . But, recently it was demonstrated that in hESCs, PI3/AKT signaling promotes self-renewal by restricting pro-differentiation cues (Singh et al., 2012) . In presence of IGF2/ Hergulin and Activin, hESC maintain the self-renewal state. IGF2/ Hergulin is responsible for the activation of PI3K/AKT signaling. Elevated PI3K/AKT activity induces SMAD2 and SMAD3 accumulation and the expression of the target gene NANOG (Singh et al., 2012) . Additionally, AKT binding to c-RAF provokes dephosphorylation of ERK. This further inhibits the interaction of ERK with GSK3 resulting in its dephosphorylation. GSK3 signaling in turn inhibits the Wnt/b-catenin pathway (Singh et al., 2012) and thus maintains the undifferentiated state of hESCs. Hence the crosstalk between different signaling pathways could mediate pluripotency in hESCs.
Signaling pathways implicated in pluripotency of ESCs from other animals
Even after 30 years of the first successful derivation of mESC (Evans & Kaufmann, 1981) , no convincing pluripotent embryonic stem cells have been reproducibly established from non-rodent or non-primates. Present literature demonstrates the establishment of only ES-like cell lines from these animals as they are deprived of major characters associated with pluripotency or true chimerism (Gandolfi et al., 2012) . Different porcine, canine, rabbit, bovine, ovine and cat ES like cells were isolated and cultured. Most of these ES like cells thrive on bFGF signaling for maintenance of pluripotency. Based on the response towards bFGF signaling, they might resemble hESCs rather than mESCs. Signaling pathways implicated in maintaining pluripotency of ES-like cells from diverse mammalian species have been summarized in Table 1 . Interestingly, few ES-like cell lines from these domesticated animals require both bFGF and LIF for the maintenance of pluripotency. So, Gandolfi et. al. in a recent review concluded that a synergistic action of bFGF and LIF on the expression of NANOG promoted the derivation of ES-like cells (Gandolfi et al., 2012) . As robust ESCs from these species are difficult to derive and maintain, so somatic cells from these species have been reprogrammed to induced pluripotent stem cells (iPSCs) with different set of genes . Most frequently but not exclusively, four genes OCT4, SOX2, KLF4 and c-MYC are expressed in these somatic cells like fibroblast to generate iPSCs. These cells exhibit a pluripotent phenotype resembling ESCs and hence can be used as an alternative to study pluripotency within these species. A recent review by Ezhashi et al., has summarized the characteristics of different set of iPSC lines generated from these animals (Ezhashi et al., 2012) .
Structural aspect for divergence
Different signaling mechanisms are implicated in maintaining pluripotency among a wide range of mammalian species. As mentioned earlier, recent evidences indicated that culture of ESCs is a heterogeneous mix of population of cells representing different state and thus fluctuate in the potency to differentiate into different lineages. This heterogeneity is present in both mESCs and hESCs (Hough et al., 2009) . Signaling molecules invoke varied responses from these heterogeneous population of cells in culture condition. But, in a broader sense, hESCs differ from mESCs in various aspects including colony morphology, capacity for colonizing pre-implantation embryo, epigenetic stability among others. Intriguingly, hESCs share common gene expression pattern and signaling responses to stems cells isolated from late epiblast layer of post-implantation mouse embryo, called Epiblast stem cells or EpiSCs (Brons et al., 2007; Tesar et al., 2007) . The mEpiSC lines are distinctively different from mESCs both in their epigenetic state as well as signaling responses regulating their differentiation. Mouse EpiSCs maintain the genomic integrity and can be propagated to major somatic cell types. Unlike mESCs Pera & Tam, 2010; Daheron et al. 2004; Telugu et al. 2011; Behboodi et al. 2011; Saito et al. 2002; Hayes et al. 2008; Maruotti et al. 2012; Gandolfi et al. 2012; Zhao et al. 2011 et al. 2003; Tan et al. 2011; Kobayashi et al. 2008; Ueda et al. 2008 , Xu et al. 2002 Wnt but alike hESCs, mEpiSCs are derived and cultured in presence of bFGF/Activin (Brons et al., 2007; Tesar et al., 2007; Grebar et al., 2010) . The pluripotency of mEpiSCs is associated with the expression of classical pluripotent markers, Nanog, Pou5f1 and Sox2 (Brons et al., 2007; Tesar et al., 2007) . Hence, a proper characterization of the pluripotent state of mEpiSCs would further enhance our understanding of hESCs. A comparative study of differential characteristics among hESCs vs. mEpiSCs is summarized in Table 2 . Mouse EpiSCs culture comprises of both early and late epiblast cells . They express different sets of markers and accordingly, only the minor fraction of early EpiSCs contribute to chimera . This further emphasizes the importance of heterogeneity in culture conditions. ESCs from species other than mouse and rat might represent the pluripotent state of mEpiSC, as they resemble hESCs. Thus, two distinct phases exist in pluripotency: one that is represented by mESCs is referred as naïve state while the other corresponding to EpiSCs is referred as primed state De Los Angeles et al., 2012) . The naïve state refers to those cells that contribute towards the chimeric embryo, maintain X chromosome activation in the female cells and are comparatively refractory to differentiate towards primordial germ cells or PGCs . They can be cloned with high efficiency, form dome shaped colonies, are responsive to LIF/STAT3 signaling and destabilized by bFGF and TGFb/Activin signaling . On the contrary, primed pluripotent state refers to those cells that have a limited capacity for colonizing preimplantation embryo; undergone X chromosome inactivation (XiXa) within the female cells and is poised for differentiation to PGCs . Their clonal propagation is inefficient, form flattened colonies, are stabilized by bFGF and TGFb/Activin signaling and are non-responsive to LIF/STAT3 signaling . Human ESCs sharing similar characteristics with mEpiSCs, represent the primed state. Even ESCs from Rhesus monkey exist in the primed state of pluripotency as they failed to colonize the pre-implantation blastocyst (Tachibana et al., 2012) . So, in effect, the derivation of naïve ESCs from domesticated animals and primates still remain Depending on the differential responses of ESCs or ES-like cells to LIF/STAT3 signaling, a phylogenetic approach has been designed to understand the structural basis of this divergence among different mammalian species. Multigene and multiprotein
Human ESCs Mouse EpiSCs References
Characteristics (differential)
Source Peri-implantation embryo Post-implantation as well as pre-implantation embryo Thompson et al. 1998; Brons et al. 2007; Tesar et al. 2007 Chimera generation No Only with pre-implantation (E5.5) and not from postimplantation (E6.5/E7.5) Thompson et al. 1998; Brons et al. 2007; Tesar et al. 2007 Blauwkamp et al. 2012; Amita et al., 2013; Tesar et al. 2007 BMP4 ( bFGF/Activin/Nodal Maintain Pluripotency Maintain Pluripotency Thompson et al. 1998; Brons et al. 2007; Tesar et al. 2007 FGF/ERK inhibition Death or differentiation Revert to mESCs Guo et al. 2009; Roode et al. 2012 studies revealed that phylogenetically, human and monkeys are the nearest relative to the rodents while they are distantly related to the domesticated animals (Hedges, 2002) . But, the phylogenetic tree derived from the alignment of Stat3 gene sequences represents a different picture (Fig. 2) . The phylogenetic tree in Fig.2 demonstrates that human and monkeys are closer to the farm animals and not rodents. Even rabbit branches with the cluster composed of these farm animals rather than the rodents. As ES like cells from domesticated animals resemble the hESCs and are responsive to bFGF signaling, this phylogenetic relationship further suggests that they might be distinct from mESCs. Hence, the phylogenetic tree predicts that unless manipulated, ESCs from the domesticated animals and rabbit might not respond to the LIF/ STAT3 signaling (Fig. 2) . Thus, the structural basis demonstrating a probable picture of deviation in signaling pathways implicated in pluripotency among diverse mammalian species could replicate the experimental findings.
Common pathway in deriving and culturing true ESCs?
So, the next question arises that in spite of spending a considerable effort on deriving and culturing ESCs from livestock for decades, what is the basic hurdle in achieving the promise of true stem cells in agriculture and how can we conquer it? The answer might lie in the fact that there is a basic difference in the development of embryo within different mammalian species . During early development of embryo, the opportunity for capturing the transient ground state in non-rodents is minimized as compared to rodents ). Additionally, absence of diapause in primates further alleviates ESC derivation . Despite this hurdle in generating naïve pluripotency, number of successful in vitro experiments has been performed to revert primed state into naïve state. Re-expression of the transcription factor KLF4 is essential in the regeneration of naïve mESCs from primed mEpiSCs or naïve hESCs from primed hESCs (Hanna et al., 2010) . Forskolin or Kellpaullone are used in culture during reversion from primed to naïve state to induce the KLF4 expression (Hanna et al., 2009 (Hanna et al., , 2010 . Downstream to JAK/STAT3 signaling, an induced Klf4 expression along with Pou5f1 could establish and maintain naïve pluripotency (van Oosten et al., 2012) . Additionally, KLF4 regulate the TERT subunit of telomerase, which is required for the maintenance of pluripotency in mESCs (Hoffmeyer et al., 2012) . Intriguingly, true porcine ESCs have been derived by the overexpression of KLF4 in the ICM of pig blastocyst (Telugu et al., 2011) . These experimental evidences strongly justify the substantial role of Klf4 in isolating or maintaining true stemness of ESCs. Expression of Klf4 is further regulated by ERK signaling (Kim et al., 2012) . In addition to Klf4 regulation, inhibition of ERK signaling is associated with the existence of mESCs in ground state of pluripotency . In non-permissive NOD mouse strain, inhibition of ERK/ GSK3 (2i) signaling enabled the derivation of naïve mESCs (Hanna et al., 2009) . Inhibition of ERK signaling is even associated with LIF/STAT3 or BMP4/SMAD signaling or in the biallelic expression of Nanog in mESCs (Miyanari & Torres-Padilla, 2012) .
On the other hand, inhibition of ERK signaling promotes death or differentiation in hESCs Guo et al., 2009) . But interestingly, inhibition of ERK signaling has been found to promote establishment of naïve hESCs from primed hESCs or in the generation of naïve hiPSCs. Yamanaka factors, especially KLF4, along with LIF/2i could generate mESC-like hiPSCs (Hanna et al., 2009) while, generation of FGF2-dependent hiPSC is independent of KLF4 expression (Huangfu et al., 2008) .
Intriguingly, inhibition of ERK signaling is responsible for the establishment of ground state of pluripotency from the mouse blastocyst. But this role of ERK signaling has been found to be highly species specific. The epiblast/hypoblast differentiation from the common ICM precursor is dependent on FGF/ERK signaling in mouse (Feldman et al., 1995) . An inhibition of ERK signaling induces NANOG expression in the epiblast cells and shuts off GATA6 in the hypoblast cells (Feldman et al., 1995) . In bovine blastocyst, ERK inhibition could induce NANOG expression without affecting hypoblast formation (Kuijk et al., 2012) . But, the segregation of hypoblast from epiblast in human embryo is independent of FGF signaling (Roode et al., 2012) . On inhibition of ERK signaling, there is no repression of GATA4 expression. Interestingly, without any deteriorating effect, 2i could still retain the NANOG positive epiblast cells (Roode et al., 2012) . This observation significantly indicates that FGF/ERK signaling independent derivation of naïve hESCs might be possible in future.
Conclusion
Defined intrinsic and extrinsic regulations contribute to the maintenance of pluripotency in ESCs from different species. But, neither of them could be universally implicated in maintaining the self-renewal or pluripotent state of ESCs from the entire range of mammalian species. Supported by experimental evidences, this review hypothesized that an induced expression of KLF4 in the ICM of non-permissive strains of non-rodent/primate/human blastocyst followed by an inhibition of ERK signaling might promote naïve state of pluripotency in ESCs. The requirement of a combinatorial action of these two factors is reflected even during the reversion of primed EpiSCs to naïve ESCs. In future, it will be highly significant to understand how ERK signaling and KLF4 overexpression could induce the generation of naïve state of pluripotency in hESCs.
